Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Can-Fite Biopharma Ltd (CANF) Return on Tangible Equity data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$8.00M |
|
$0.01M |
|
$0.05M |
|
$8.05M |
|
$2.23M |
|
-- |
|
$0.97M |
|
$3.20M |
|
$4.86M |
|
$4.86M |
|
$4.86M |
|
2.14M |
|
| Cash Flow Statement Financials | |
$-5.31M |
|
$-1.00M |
|
$3.77M |
|
$5.53M |
|
$2.98M |
|
$-2.54M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|